Droxidopa
Total Payments
$421,688
Transactions
2
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $421,688 | 2 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $421,688 | 2 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Droxidopa Capsules, 300 mg, Pivotal Fasted Study | West-Ward Pharmaceuticals | $210,844 | 0 |
| Droxidopa Capsules, 300 mg, Pivotal Fed Study | West-Ward Pharmaceuticals | $210,844 | 0 |
Top Doctors Receiving Payments for Droxidopa
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Columbia, MO | $421,688 | 2 |
Ad
Manufacturing Companies
- West-Ward Pharmaceuticals $421,688
Product Information
- Type Drug
- Total Payments $421,688
- Total Doctors 0
- Transactions 2
About Droxidopa
Droxidopa is a drug associated with $421,688 in payments to 0 healthcare providers, recorded across 2 transactions in the CMS Open Payments database. The primary manufacturer is West-Ward Pharmaceuticals.
Payment data is available from 2018 to 2018. In 2018, $421,688 was paid across 2 transactions to 0 doctors.
The most common payment nature for Droxidopa is "Unspecified" ($421,688, 100.0% of total).
Droxidopa is associated with 2 research studies, including "Droxidopa Capsules, 300 mg, Pivotal Fasted Study" ($210,844).